12:00 AM
Jan 17, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Serono Pharmaceutical Research Institute preclinical data

Serono researchers and colleagues published in The Lancet that in a cell culture model a 13-amino acid peptide partly reversed the pathological conformation of prion...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >